A Handling Study to Assess the Use of the Respimat® Soft Mist™ Inhaler in Children Aged 4–12 Years

This publication has 16 references indexed in Scilit:

• In Vitro Determination of Respimat ^® Dose Delivery in Children: An Evaluation Based on Inhalation Flow Profiles and Mouth–Throat Models
  Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2015
• Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy
  Expert Review of Respiratory Medicine, 2011
• The DiskusTM: a review of its position among dry powder inhaler devices
  International Journal Of Clinical Practice, 2007
• Schulung des Inhalationsmanövers bei Kindern mit Asthma bronchiale mittels optischem Feedback
  Pneumologie, 2007
• Comparison of the Aerosol Velocity and Spray Duration of Respimat® Soft Mist™ Inhaler and Pressurized Metered Dose Inhalers
  Journal of Aerosol Medicine, 2005
• Deposition of Corticosteroid Aerosol in the Human Lung by Respimat® Soft Mist™ Inhaler Compared to Deposition by Metered Dose Inhaler or by Turbuhaler® Dry Powder Inhaler
  Journal of Aerosol Medicine, 2005
• Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines
  Chest, 2005
• Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat® Soft Mist™ Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma
  Pediatric Pulmonology, 2004
• A Review of Ipratropium Bromide/Fenoterol Hydrobromide (Berodual??) Delivered Via Respimat?? Soft Mist??? Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Disease
  Drugs, 2004
• Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone
  European Respiratory Journal, 1998